Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling.
Animal Study Design
Internal Concentrations
Nonlinear Pharmacokinetics
Physiologically Based Pharmacokinetic (PBPK)
Saturation of Absorption
Saturation of Clearance
Journal
Toxicology and applied pharmacology
ISSN: 1096-0333
Titre abrégé: Toxicol Appl Pharmacol
Pays: United States
ID NLM: 0416575
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
08
12
2021
revised:
19
01
2022
accepted:
10
02
2022
pubmed:
18
2
2022
medline:
30
4
2022
entrez:
17
2
2022
Statut:
ppublish
Résumé
Although external concentrations are more readily quantified and often used as the metric for regulating and mitigating exposures to environmental chemicals, the toxicological response to an environmental chemical is more directly related to its internal concentrations than the external concentration. The processes of absorption, distribution, metabolism, and excretion (ADME) determine the quantitative relationship between the external and internal concentrations, and these processes are often susceptible to saturation at high concentrations, which can lead to nonlinear changes in internal concentrations that deviate from proportionality. Using generic physiologically-based pharmacokinetic (PBPK) models, we explored how saturable absorption or clearance influence the shape of the internal to external concentration (IEC) relationship. We used the models for hypothetical chemicals to show how differences in kinetic parameters can impact the shape of an IEC relationship; and models for styrene and caffeine to explore how exposure route, frequency, and duration impact the IEC relationships in rat and human exposures. We also analyzed available plasma concentration data for 2,4-dichlorophenoxyacetic acid to demonstrate how a PBPK modeling approach can be an alternative to common statistical methods for analyzing dose proportionality. A PBPK modeling approach can be a valuable tool used in the early stages of a chemical safety assessment program to optimize the design of longer-term animal toxicity studies or to interpret study results.
Identifiants
pubmed: 35176293
pii: S0041-008X(22)00067-9
doi: 10.1016/j.taap.2022.115922
pmc: PMC10519136
mid: NIHMS1930677
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
115922Subventions
Organisme : Intramural EPA
ID : EPA999999
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Références
Carcinogenesis. 1999 May;20(5):867-78
pubmed: 10334205
Future Sci OA. 2017 Jan 16;3(1):FSO167
pubmed: 28344830
Pharmacol Rep. 2008 Nov-Dec;60(6):789-97
pubmed: 19211970
Toxicol Sci. 2013 Jul;134(1):180-94
pubmed: 23596260
J Pharm Sci. 2017 Mar;106(3):734-737
pubmed: 27915208
Toxicol Sci. 2020 Sep 1;177(1):60-70
pubmed: 32514576
Crit Rev Toxicol. 2020 Oct;50(9):725-739
pubmed: 33236972
Biomed Chromatogr. 2007 Feb;21(2):190-200
pubmed: 17221922
Clin Pharmacol Ther. 1982 Jul;32(1):98-106
pubmed: 7083737
Toxicol Sci. 2004 May;79(1):28-37
pubmed: 14976335
Toxicol Ind Health. 1997 Jul-Aug;13(4):407-84
pubmed: 9249929
Regul Toxicol Pharmacol. 2012 Jul;63(2):344-51
pubmed: 22487418
Arch Toxicol. 2021 Dec;95(12):3651-3664
pubmed: 34623454
AAPS J. 2009 Mar;11(1):45-53
pubmed: 19184451
Crit Rev Toxicol. 2014 May;44 Suppl 2:1-14
pubmed: 24832550
Regul Toxicol Pharmacol. 2021 Dec;127:105070
pubmed: 34718074
Regul Toxicol Pharmacol. 2021 Dec;127:105052
pubmed: 34653552
Regul Toxicol Pharmacol. 1990 Oct;12(2):107-16
pubmed: 2259752
J Appl Toxicol. 2017 May;37(5):621-640
pubmed: 27885692
Regul Toxicol Pharmacol. 2021 Jul;123:104931
pubmed: 33905778
Eur J Pharm Sci. 2017 Jan 1;96:610-625
pubmed: 27816631
Regul Toxicol Pharmacol. 2020 Oct;116:104714
pubmed: 32640299
Drug Metab Dispos. 2007 Apr;35(4):649-59
pubmed: 17267621
Xenobiotica. 2003 Aug;33(8):805-21
pubmed: 12936702
Toxicol Sci. 2013 Dec;136(2):294-307
pubmed: 24105888
Environ Health Perspect. 2002 Jan;110(1):85-93
pubmed: 11781169
J Pharm Sci. 1997 May;86(5):584-90
pubmed: 9145383
J Pharm Pharmacol. 2016 Dec;68(12):1501-1515
pubmed: 27781273
J Antimicrob Chemother. 2017 Apr 1;72(4):1129-1136
pubmed: 28039274
Regul Toxicol Pharmacol. 2020 Jun;113:104644
pubmed: 32194133
Regul Toxicol Pharmacol. 2021 Aug;124:104962
pubmed: 34019964
J Stat Softw. 2017 Jul 17;79(4):1-26
pubmed: 30220889
Toxicol Appl Pharmacol. 1984 Mar 30;73(1):159-75
pubmed: 6710512
Regul Toxicol Pharmacol. 2012 Jul;63(2):321-32
pubmed: 22440553
Arch Toxicol. 2017 May;91(5):2045-2065
pubmed: 27928627